Binance Square
#saude

saude

8,475 views
10 Discussing
TechCripto
·
--
Novo Nordisk, owner of Ozempic, bets on Anthropic's AIThe Danish pharmaceutical company will test Claude Science in research and development, in the year's third AI alliance, after OpenAI and AWS. Novo Nordisk, maker of Ozempic and Wegovy, announced this Wednesday (16) a collaboration with Anthropic, the creator of Claude. According to Novo Nordisk's official statement, the goal is to accelerate the development of new medicines and expand the use of AI in creating software. In practice, the two companies will tackle drug discovery bottlenecks identified by Novo's scientists. As a first step, the pharmaceutical company will test Claude Science in specific research and development (R&D) workflows.

Novo Nordisk, owner of Ozempic, bets on Anthropic's AI

The Danish pharmaceutical company will test Claude Science in research and development, in the year's third AI alliance, after OpenAI and AWS.
Novo Nordisk, maker of Ozempic and Wegovy, announced this Wednesday (16) a collaboration with Anthropic, the creator of Claude. According to Novo Nordisk's official statement, the goal is to accelerate the development of new medicines and expand the use of AI in creating software.
In practice, the two companies will tackle drug discovery bottlenecks identified by Novo's scientists. As a first step, the pharmaceutical company will test Claude Science in specific research and development (R&D) workflows.
Log in to explore more content
Join global crypto users on Binance Square
⚡️ Get latest and useful information about crypto.
💬 Trusted by the world’s largest crypto exchange.
👍 Discover real insights from verified creators.
Email / Phone number